Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd.
  6. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD.

(4519)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
4100 4101 4020 4088 4004 Last
2740600 1594900 2058900 1741700 2048900 Volume
-1.44% +0.02% -1.98% +1.69% -2.05% Change
Estimated financial data (e)
Sales 2021 848 B 7 777 M 7 777 M
Net income 2021 254 B 2 326 M 2 326 M
Net cash position 2021 504 B 4 619 M 4 619 M
P/E ratio 2021 26,0x
Yield 2021 1,56%
Sales 2022 845 B 7 744 M 7 744 M
Net income 2022 238 B 2 180 M 2 180 M
Net cash position 2022 599 B 5 493 M 5 493 M
P/E ratio 2022 27,7x
Yield 2022 1,62%
Capitalization 6 583 B 60 351 M 60 357 M
EV / Sales 2021 7,17x
EV / Sales 2022 7,08x
Nbr of Employees 7 555
Free-Float 37,7%
More Financials
Company
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the... 
Sector
Pharmaceuticals
Calendar
10/22 | 04:00amEarnings Release
More about the company
Ratings of Chugai Pharmaceutical Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CHUGAI PHARMACEUTICAL CO., LTD.
08/02CHUGAI PHARMACEUTICAL : Launches FoundationOne Liquid CDx Cancer Genomic Profile..
PU
07/30CHUGAI PHARMACEUTICAL : Continues to be Listed for All ESG Indices Selected by G..
PU
07/29PRESS RELEASE : FDA accepts application for -2-
DJ
07/29PRESS RELEASE : Data for Roche's Evrysdi(R) -2-
DJ
07/28CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
07/26Chugai Pharmaceutical Co., Ltd. Provides Year-End Dividend Guidance for the F..
CI
07/26Chugai Pharmaceutical Co., Ltd. Provides Earnings Guidance for the First Half..
CI
07/26Chugai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Half E..
CI
07/26CHUGAI PHARMACEUTICAL : CONSOLIDATED FINANCIAL STATEMENTS (IFRS)(Non-Audited)(fo..
PU
07/26CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Resul..
PU
07/26CHUGAI PHARMACEUTICAL : Construction of API Manufacturing Building for Late Stag..
PU
07/26CHUGAI PHARMACEUTICAL : Organizational and Personnel Changes
PU
07/26CHUGAI PHARMACEUTICAL : Announces 2021 Half Year Results
PU
07/26CHUGAI PHARMACEUTICAL : Presentation
PU
07/26Chugai Pharmaceutical Co., Ltd. Announces Construction of API Manufacturing B..
CI
More news
News in other languages on CHUGAI PHARMACEUTICAL CO., LTD.
07/27MÄRKTE ASIEN/Erneut schwere Verluste in Hongkong und Schanghai
07/27MÄRKTE ASIEN/Freundlich - Stimmung in Hongkong weiter schlecht
06/30++ Analysen des Tages von Dow Jones Newswires (30.6.2021) +++
06/30MÄRKTE ASIEN/Mehrheitlich fester - Gewinnmitnahmen in Hongkong
06/30TOKYO N'A PAS SU REBONDIR (NIKKEI : -0,07%)
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD.
More recommendations
Chart CHUGAI PHARMACEUTICAL CO., LTD.
Duration : Period :
Chugai Pharmaceutical Co., Ltd. Technical Analysis Chart | 4519 | JP3519400000 | MarketScreener
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 4 004,00 JPY
Average target price 4 670,00 JPY
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Chairman & Chief Executive Officer
Osamu Okuda President, COO & Representative Director
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD.-27.24%61 539
JOHNSON & JOHNSON9.46%453 498
ROCHE HOLDING AG13.88%339 298
PFIZER, INC.19.42%246 075
NOVARTIS AG0.14%225 528
ELI LILLY AND COMPANY46.06%224 166